CX-5461 is the first G-quadruplex (G4) stabilizer in development. It has shown promising activity in early-phase trials for ...

Novo Nordisk received approval from the U.S. FDA for the Wegovy pill (once-daily oral semaglutide 25 mg) to reduce excess ...

Transcenta Therapeutics, a global biopharmaceutical company with capabilities in discovery, research, development and ...

Akari Therapeutics, Plc, an oncology biotechnology company developing antibody drug conjugates (ADCs) with novel payloads, ...

BioMarin adds scale of operations, including global commercial footprint and in-house manufacturing capabilities for rare ...

What defined pharma in 2025? Contract Pharma’s most‑viewed breaking news offers insights. Here’s your yearly recap—the most ...

Rectify Pharmaceuticals has entered a strategic research and licensing agreement with Boehringer Ingelheim to accelerate the ...

Samsung Biologics America, a subsidiary of Samsing Biologics, a CDMO, has entered into a definitive agreement to acquire 100% ...

Gilead Sciences Inc. has appointed Keeley Wettan as Executive Vice President, General Counsel, Legal & Compliance effective ...

Lubrizol offers an array of pharmaceutical excipients for oral, topical and injectable applications. The company’s portfolio ...

Nine leading global pharmaceutical companies announced broad agreements with the Trump administration on Friday to lower the ...

Samsung Bioepis Co. Ltd. has announced the marketing approval of Ustekinumab BS Subcutaneous Injection 45mg Syringes 'NIPRO', ...